The Current Ratio as of September 2024 (TTM) for Sio Gene Therapies Inc. (SIOX) is 21.97

According to Sio Gene Therapies Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 21.97. This represents a change of 94.98% compared to the average of 11.27 of the last 4 quarters.

Sio Gene Therapies Inc. (SIOX) Historical Current Ratio (quarterly & annually)

How has SIOX Current Ratio performed in the past?

The mean historical Current Ratio of Sio Gene Therapies Inc. over the last ten years is 6.17. The current 21.97 Current Ratio has changed 35.51% with respect to the historical average. Over the past ten years (40 quarters), SIOX's Current Ratio was at its highest in in the June 2015 quarter at 72.47. The Current Ratio was at its lowest in in the December 2019 quarter at 1.09.

Sio Gene Therapies Inc. (SIOX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Sio Gene Therapies Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sio Gene Therapies Inc. (SIOX) Average Current Ratio

How has SIOX Current Ratio performed in the past?

The current Current Ratio of Sio Gene Therapies Inc. (SIOX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Sio Gene Therapies Inc. (SIOX) Current Ratio vs. Peers

How is SIOX’s Current Ratio compared to its peers?

Sio Gene Therapies Inc.’s Current Ratio is greater than Magenta Therapeutics, Inc. (14.64), less than TRACON Pharmaceuticals, Inc. (0), greater than ARCA biopharma, Inc. (0.66), less than Neoleukin Therapeutics, Inc. (26.61), greater than CytomX Therapeutics, Inc. (15.33), greater than Assembly Biosciences, Inc. (1.00), greater than Instil Bio, Inc. (2.74), greater than Nuvation Bio Inc. (15.06), greater than Rezolute, Inc. (11.49), greater than XOMA Corporation (11.82), greater than Vincerx Pharma, Inc. (8.71), greater than Protara Therapeutics, Inc. (3.43), greater than Vaccinex, Inc. (16.33), greater than Monopar Therapeutics Inc. (0.42), greater than Miromatrix Medical Inc. (6.59), greater than Surrozen, Inc. (3.46), greater than Tempest Therapeutics, Inc. (6.96), greater than SAB Biotherapeutics, Inc. (2.17), greater than Aligos Therapeutics, Inc. (5.24), greater than Molecular Partners AG (4.23), greater than null (14.58),

Build a custom stock screener for Sio Gene Therapies Inc. (SIOX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sio Gene Therapies Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sio Gene Therapies Inc. (SIOX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sio Gene Therapies Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.